FDA Says Maker of Recalled Eye Drops Failed to Follow Multiple Safety Protocols

The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.

The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.

The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.

When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.

More In Business

Video Game Performers Will Strike Over AI concerns

Hollywood’s video game performers are going on strike, throwing part of the entertainment industry into another work stoppage.

Widespread Gains Send Wall Street Higher To Close a Shaky week

U.S. stocks climbed Friday to close out a bumpy week dominated by sharp, market-cleaving swings.

Tech Stocks’ Terrible, Horrible, No Good, Very Bad Week

Pretty much all the tech stocks driving the market were looking shaky—and they weren't the only ones.

Small Stocks Are About to Take over? Wall Street Is Unconvinced...

Some of the smallest stocks on Wall Street have shown much more life recently. but professional investors still aren’t convinced.

Global Shares Tumble after Big Tech’s Wipeout on Wall Street

Global shares have dropped as pessimism set in over Wall Street's nose-dive related to Big Tech's pullback.

Domino's Q2: Strong Growth Amidst Inflation and Future Challenges

Domino’s Pizza reported a 7.1% revenue rise to $1.1B amid value meal competition and inflation. Q3 may slow, with caution on growth and consumer spending.

Load More